Actively Recruiting
Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs
Led by Assiut University · Updated on 2026-01-02
60
Participants Needed
1
Research Sites
319 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
In our study, we assess the diaphragmatic function, pain quality and anti-inflammatory properties between low dose infusion of dexmedetomidine normal saline in patients with multiple fracture ribs on conservative treatment.
CONDITIONS
Official Title
Low Dose Dexmedetomidine Versus Normal Saline in Multiple Fracture Ribs
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 65 years with ASA physical status I-II
- Traumatic multiple rib fractures involving three or more ribs confirmed by chest 3D-CT
- Receiving conservative treatment such as chest strappings
- Experiencing intractable pain with a visual analogue scale over 6 despite traditional therapies
- Glasgow Coma Scale score of 13 or higher
You will not qualify if you...
- Multiple traumatic injuries to other body parts with an abbreviated injury scale over 3
- Serious head trauma with Glasgow Coma Scale less than 13
- Patients requiring mechanical ventilation
- Presence of massive hemothorax
- Injury to trachea or bronchus necessitating immediate surgery
- Dementia diagnosis
- Use of corticosteroids during ICU stay
- Sepsis
- Ongoing use of neuromuscular blocking agents or aminoglycoside antibiotics
- Known hypersensitivity or contraindication to the study drugs
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Assiut university hospital
Asyut, Assuit, Egypt, Assuit universi
Actively Recruiting
Research Team
O
Omar Soliman, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here